Navigation Links
Jazz Pharmaceuticals Announces First Quarter 2011 Results Conference Call on May 3
Date:4/21/2011

PALO ALTO, Calif., April 21, 2011 /PRNewswire/ -- Jazz Pharmaceuticals, Inc. (Nasdaq: JAZZ) today announced that it will host a conference call and live webcast on Tuesday, May 3, 2011 at 4:30 p.m. Eastern Time/1:30 p.m. Pacific Time.  During the call, company management will provide a business and financial update and review first quarter 2011 results.  

The live webcast and press release may be accessed from the Investors section of the Jazz Pharmaceuticals' website at www.jazzpharmaceuticals.com.  Please connect to the website prior to the start of the conference call to ensure adequate time for any software downloads that may be necessary to listen to the webcast. An archived version of the webcast will be available for at least one week.

Investors may participate in the conference call by dialing 1-866-510-0712 in the U.S., or 1-617-597-5380 outside the U.S., and entering passcode 13279408.

About Jazz Pharmaceuticals, Inc.

Jazz Pharmaceuticals (Nasdaq: JAZZ) is a specialty pharmaceutical company that identifies, develops and commercializes innovative treatments for important, underserved markets in neurology and psychiatry. For further information see www.jazzpharmaceuticals.com.


'/>"/>
SOURCE Jazz Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Important Drug Product Notice: Luitpold Pharmaceuticals, Inc. Announces Temporary Suspension of Distribution and Manufacture of Drug Products
2. Onyx Pharmaceuticals Announces First Quarter 2011 Financial Results Teleconference and Webcast
3. Savient Pharmaceuticals to Hold First Quarter 2011 Financial Results
4. Fleming Pharmaceuticals Now Ready to Step Up Production of Nuclear Radiation Safeguard, ThyroShield®
5. Marinus Pharmaceuticals Announces Commencement of Phase 2 Trial of Ganaxolone for the Treatment of Posttraumatic Stress Disorder
6. Hanmi Pharmaceuticals to Acquire the Rights for a Promising Phase II Anti-cancer Src Kinase/Pretubulin Dual Inhibitor from Kinex Pharmaceuticals, in Selected Asian Territories
7. Merrimack Pharmaceuticals Announces that Recruitment is Open in a Phase 1 Combination Study of MM-111 with Multiple Treatment Regimens in HER2 Positive Patients
8. Valeant Pharmaceuticals Announces Redemption of 4.0% Convertible Subordinated Notes Due 2013
9. Auxilium Pharmaceuticals to Present at the Deutsche Bank 36th Annual Health Care Conference
10. Sagent Pharmaceuticals Upsizes and Prices Initial Public Offering
11. Amira Pharmaceuticals Receives Orphan Drug Status for a Novel LPA1 Antagonist, AM152, for the Treatment of Idiopathic Pulmonary Fibrosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2017)... Direct-to-consumer digital marketing strategy drives 85% ... in consumable sales, quarter-over-quarter ... ), a leader in digital health and mobile health ... Monitoring System, an all-in-one diabetes meter, today announced continued ... smart diabetes management solution. In just ...
(Date:1/23/2017)... 2017 Research and Markets has announced the addition ... Product - Forecast to 2025" report to their offering. ... Report Highlights: ... to identify the investment opportunities Market forecasts till 2025, ... market trends across the business segments, Regions and Countries ...
(Date:1/23/2017)... NEW YORK , January 23, 2017 ... Biotech equities to see how they have fared at the close: ... BPMX), OvaScience Inc. (NASDAQ: OVAS ), and Regeneron Pharmaceuticals ... the NASDAQ, Biotechnology shares were relative laggards on Friday, January 20 ... can access our complimentary research reports on these stocks now at: ...
Breaking Medicine Technology:
(Date:1/24/2017)... ... January 24, 2017 , ... “The Octagon of Spiritual Balances”: a ... Balances” is the creation of published author, Pastor Bernard J. Weathers, pastor of Word ... bachelor degree in religious education and a master degree in theology. , ““The Octagon ...
(Date:1/24/2017)... PA (PRWEB) , ... January 24, 2017 , ... ... breast implants, a new scientific article suggests that autologous fat grafting—taking ... for achieving larger breasts naturally, without breast implants. , Cosmetic Surgeon and ...
(Date:1/24/2017)... ... January 23, 2017 , ... The Pharmacy and ... with the bipartisan original co-sponsorship of nearly one-quarter of the U.S. House of ... Association of Chain Drug Stores (NACDS) strongly backs the legislation. , “NACDS thanks ...
(Date:1/24/2017)... ... January 23, 2017 , ... United Nations Foundation President and ... Mexico City Policy, also known as the Global Gag Rule, last enacted in ... foreign non-governmental organizations from receiving any U.S. foreign assistance for family planning if ...
(Date:1/24/2017)... ... January 23, 2017 , ... ... with the acquisitions of two personal care service companies: Padre Home Health in ... effective January 1, 2017. , Well regarded in their respective markets, these two ...
Breaking Medicine News(10 mins):